Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

autologous gene-modified PD-1-positive T lymphocytes ScTIL210

A preparation of autologous programmed cell death protein 1 (PD-1; PDCD1; CD279)-positive T lymphocytes transduced with a lentiviral vector encoding for an as of yet undisclosed receptor, with potential immunomodulating activity. Upon administration, autologous gene-modified PD-1-positive T lymphocytes ScTIL210 may recognize and kill the patient's tumor cells through as of yet not elucidated receptor binding.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:autologous gene-modified PD-1-positive T cells ScTIL210
Code name:ScTIL 210
ScTIL-210
ScTIL210
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search